Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Richter

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
Blood Cancer Discovery|October 18, 2021
Bispecific Antibodies in Multiple Myeloma: Present and FutureGuido Lancman, Dahniel L Sastow, Hearn J Cho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 4, 2016
A Phase I/II Study of Escalating Doses of Bortezomib in Conjunction with High-Dose Melphalan as a Conditioning Regimen for Salvage Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple MyelomaNoa Biran, Scott D Rowley, David H Vesole, et al.
Bone Marrow Transplantation|July 31, 2024
Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myelomaZachary M Avigan, Suzanne Arinsburg, Darren Pan, et al.
American Journal of Hematology|October 6, 2022
Trial designs and endpoints for immune therapies in multiple myelomaGuido Lancman, Erin Moshier, Hearn Jay Cho, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 16, 2024
Addition of Elotuzumab to Backbone Treatment Regimens for Multiple Myeloma: An Updated Meta-Analysis of Randomized Clinical TrialsBruno Almeida Costa, Thomaz Alexandre Costa, Gabriel Cavalcante Lima Chagas, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 15, 2021
Efficacy of Intravenous Immunoglobulin for Preventing Infections in Patients with Multiple MyelomaGuido Lancman, Katleen Lozada, Nida Athar, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 5, 2021
The Safety and Efficacy of Radiation Therapy with Concurrent Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin-Based Systemic Therapy for Multiple MyelomaAnthony D Nehlsen, Kunal K Sindhu, Erin Moshier, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2020
Timing of Autologous Stem Cell Transplantation for Multiple Myeloma in the Era of Current TherapiesSiyang Leng, Erin Moshier, Douglas Tremblay, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 28, 2020
Prevalence and Survival Impact of Self-Reported Symptom and Psychological Distress Among Patients With Multiple MyelomaJoshua Richter, Larysa Sanchez, Noa Biran, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 23, 2016
Vorinostat in Combination With Lenalidomide and Dexamethasone in Lenalidomide-Refractory Multiple MyelomaElizabeth Bilotti, David H Vesole, Laura McBride, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Blood Cancer Discovery|October 18, 2021
Bispecific Antibodies in Multiple Myeloma: Present and FutureGuido Lancman, Dahniel L Sastow, Hearn J Cho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 4, 2016
A Phase I/II Study of Escalating Doses of Bortezomib in Conjunction with High-Dose Melphalan as a Conditioning Regimen for Salvage Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple MyelomaNoa Biran, Scott D Rowley, David H Vesole, et al.
Bone Marrow Transplantation|July 31, 2024
Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myelomaZachary M Avigan, Suzanne Arinsburg, Darren Pan, et al.
American Journal of Hematology|October 6, 2022
Trial designs and endpoints for immune therapies in multiple myelomaGuido Lancman, Erin Moshier, Hearn Jay Cho, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 16, 2024
Addition of Elotuzumab to Backbone Treatment Regimens for Multiple Myeloma: An Updated Meta-Analysis of Randomized Clinical TrialsBruno Almeida Costa, Thomaz Alexandre Costa, Gabriel Cavalcante Lima Chagas, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 15, 2021
Efficacy of Intravenous Immunoglobulin for Preventing Infections in Patients with Multiple MyelomaGuido Lancman, Katleen Lozada, Nida Athar, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 5, 2021
The Safety and Efficacy of Radiation Therapy with Concurrent Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin-Based Systemic Therapy for Multiple MyelomaAnthony D Nehlsen, Kunal K Sindhu, Erin Moshier, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2020
Timing of Autologous Stem Cell Transplantation for Multiple Myeloma in the Era of Current TherapiesSiyang Leng, Erin Moshier, Douglas Tremblay, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 28, 2020
Prevalence and Survival Impact of Self-Reported Symptom and Psychological Distress Among Patients With Multiple MyelomaJoshua Richter, Larysa Sanchez, Noa Biran, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 23, 2016
Vorinostat in Combination With Lenalidomide and Dexamethasone in Lenalidomide-Refractory Multiple MyelomaElizabeth Bilotti, David H Vesole, Laura McBride, et al.
Pageof 11